XML 47 R28.htm IDEA: XBRL DOCUMENT v3.8.0.1
Segment Information
12 Months Ended
Dec. 31, 2017
Segment Reporting [Abstract]  
Segment Information
Segment Information
Segment reporting is prepared on the same basis that the Company’s chief executive officer, who is the Company’s chief operating decision maker, manages the business, makes operating decisions and assesses performance. The Company operates in one segment, pharmaceuticals. Enterprise-wide disclosures about revenues, significant customers, and property and equipment, net by location are presented below.
Revenues by Product
Product revenues, net consisted of the following:
 
2017
 
2016
 
2015
 
(in thousands)
ORKAMBI
$
1,320,850

 
$
979,590

 
$
350,663

KALYDECO
844,630

 
703,432

 
631,674

    INCIVEK

 
610

 
17,987

      Total product revenues, net
$
2,165,480

 
$
1,683,632

 
$
1,000,324


Revenues by Geographic Location
Net product revenues are attributed to countries based on the location of the customer. Collaborative and royalty revenues are attributed to countries based on the location of the Company’s subsidiary associated with the collaborative arrangement related to such revenues. Total revenues from external customers and collaborators by geographic region consisted of the following:
 
2017
 
2016
 
2015
 
(in thousands)
United States
$
1,986,786

 
$
1,321,807

 
$
763,316

Outside of the United States
 
 
 
 
 
Europe
420,317

 
320,456

 
219,596

Other
81,549

 
59,914

 
49,424

Total revenues outside of the United States
501,866

 
380,370

 
269,020

Total revenues
$
2,488,652

 
$
1,702,177

 
$
1,032,336


In 2017, 2016 and 2015, revenues attributable to the U.K. were the largest contributor to the Company’s European revenues.
Significant Customers
Gross revenues and accounts receivable from each of the Company’s customers who individually accounted for 10% or more of total gross revenues and/or 10% or more of total gross accounts receivable consisted of the following:
 
Percent of Total Gross Revenues
 
Percent of Gross Accounts Receivable
 
Year Ended December 31,
 
As of December 31,
 
2017
 
2016
 
2015
 
2017
 
2016
Walgreen Co.
17
%
 
19
%
 
20
%
 
20
%
 
15
%
Accredo/Curascript
14
%
 
15
%
 
15
%
 
12
%
 
10
%
CVS/Caremark
<10
%
 
19
%
 
17
%
 
n/a

 
17
%

Property and Equipment, Net by Location
Property and equipment, net by location consisted of the following:
 
As of December 31,
 
2017
 
2016
 
(in thousands)
United States
$
753,128

 
$
665,552

Outside of the United States
 
 
 
United Kingdom
31,279

 
26,921

Other
5,030

 
5,889

Total property and equipment, net outside of the United States
36,309

 
32,810

      Total property and equipment, net
$
789,437

 
$
698,362